January 30, 2013 ~ On this half day of trial in the Linda Gross v. Ethicon case being heard in an Atlantic City courtroom, psychiatrist Dr. Ronni Seltzer was on the stand. She conducted two evaluations of Linda Gross and determined the focus of her life, along with her husband Jeff, is pain that permeates
[continue reading...]
January 14, 2013 ~ During day three of the trial that’s put the spotlight on Johnson & Johnson (J&J) and its transvaginal mesh, Prolift, the primary care doctor for patient Linda Gross outlined the countless procedures she has faced to remove synthetic mesh that continues to cause crippling pain. MDND thanks Courtroom View Network for
[continue reading...]
August 8, 2012 ~ An appeals court ruling in Mississippi has upheld a lower court dismissal of a $10 million vaginal mesh case against Johnson & Johnson’s Ethicon division. The United States Court of Appeals Fifth Circuit filed the decision August 2, 2012 in the case against Ethicon by Deborah and Michael Smith. Deborah Smith
[continue reading...]
If you are considering filing a legal action, you’ve probably heard the term “Statute of Limitations.” A “statute” is the common law that sets the time frame within which you have to file a lawsuit. A filing outside of that time frame may mean it is too late to prosecute the person or company responsible
[continue reading...]
April 9, 2012 ~ On Friday, April 6, American Medical Systems Inc. (AMS) of Minnetonka, Minnesota filed its Position Statement with federal court in the Southern District of West Virginia laying out its strategy in its defense of its synthetic surgical mesh used to treat female conditions of pelvic organ prolapse (POP) and stress urinary
[continue reading...]
March 21 ~ Bloomberg is reporting (here) that major medical device maker Johnson & Johnson (J&J) sold the Gynecare Prolift surgical mesh for three years before it was approved by the U.S. Food and Drug Administration (FDA). The mesh is now the subject of more than 550 lawsuits, reports Bloomberg. Prolift is a pre-cut mesh
[continue reading...]
